Clinical Trials Directory

Trials / Completed

CompletedNCT01139645

The Effect of Proton Pump Inhibitors on Calcium and Bone Metabolism

The Effect of Proton Pump Inhibitors on Calcium and Bone Metabolism: A Prospective Single-Blind Matched Controlled Study

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
58 (actual)
Sponsor
American University of Beirut Medical Center · Academic / Other
Sex
Male
Age
18 Years – 50 Years
Healthy volunteers
Accepted

Summary

This prospective, single-blind, matched controlled study aims to evaluate the effect of proton pump inhibitors on biochemical markers of calcium and bone metabolism in an effort to establish additional biological plausibility for the apparent association between proton pump inhibitors (PPIs) and osteoporosis-related fractures. Young males (age 18-45 years), who are either healthy volunteers, or who complain of daily or frequent heartburn but are otherwise healthy, will be recruited and enrolled in the study. Patients with heartburn will be assigned to the intervention group and will be assigned to take a PPI for three months. Healthy volunteers will be matched by age to patients in the intervention group and will act as the control group. 70 patients will be enrolled in total. Blood studies for all subjects will be taken at 0, 1 and 3 months to test for various biochemical markers of calcium and bone metabolism, which act as surrogate markers of calcium absorption and bone remodeling. Levels of biochemical markers in the two groups will be compared using two-way analysis of variance (ANOVA). Changes in biochemical parameters within a group will be assessed using repeated measures ANOVA.

Conditions

Interventions

TypeNameDescription
DRUGRabeprazole or Esomeprazole or Lanzoprazole1/3 of the patients are taking Pariet (Rabeprazole) 20 mg once daily 1/3 of the patients are taking Nexium (Esomeprazole) 40 mg once daily 1/3 of the patients are taking Lanzor (Lanzoprazole) 30 mg once daily

Timeline

Start date
2009-10-01
Primary completion
2010-07-01
Completion
2010-07-01
First posted
2010-06-08
Last updated
2013-01-28

Locations

1 site across 1 country: Lebanon

Source: ClinicalTrials.gov record NCT01139645. Inclusion in this directory is not an endorsement.